Quick Answer
Insight Molecular Diagnostics Inc. reported Cash And Cash Equivalents At Carrying Value of $11.58 million for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +34.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $82.0 thousand | Q2 2015: $2.40 million | Q3 2015: $9.41 million | Q1 2016: $5.86 million | Q2 2016: $4.00 million | Q3 2016: $12.67 million | Q1 2017: $11.35 million | Q2 2017: $8.64 million | Q3 2017: $11.02 million | Q4 2017: $7.60 million | Q1 2018: $12.61 million | Q2 2018: $10.29 million | Q3 2018: $10.82 million | Q4 2018: $8.03 million | Q1 2019: $39.26 million | Q2 2019: $35.83 million | Q3 2019: $19.44 million | Q1 2020: $16.58 million | Q2 2020: $16.80 million | Q3 2020: $10.29 million | Q1 2021: $58.91 million | Q2 2021: $46.47 million | Q3 2021: $43.34 million | Q1 2022: $20.41 million | Q2 2022: $44.84 million | Q3 2022: $32.05 million | Q1 2023: $11.80 million | Q2 2023: $17.37 million | Q3 2023: $13.78 million | Q1 2024: $5.58 million | Q2 2024: $9.26 million | Q3 2024: $3.36 million | Q1 2025: $31.03 million | Q2 2025: $24.29 million | Q3 2025: $18.69 million.
- Over the full 13 years of available data (2013 to 2025), Insight Molecular Diagnostics Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 11,368.3%.
- Historical annual values: Fiscal year 2025: $11.58 million | Fiscal year 2024: $8.64 million | Fiscal year 2023: $9.43 million | Fiscal year 2022: $19.99 million | Fiscal year 2021: $32.95 million | Fiscal year 2020: $7.14 million | Fiscal year 2019: $22.07 million | Fiscal year 2018: $8.03 million | Fiscal year 2017: $7.60 million | Fiscal year 2016: $10.17 million | Fiscal year 2015: $8.00 million | Fiscal year 2014: $257.0 thousand | Fiscal year 2013: $101.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: